Table 1 Description of patients
From: Long-term renal graft outcome after parathyroidectomy - a retrospective single centre study
Age (mean ± SD) | 47.7 ± 11.4 |
Gender (male/female) | 25 / 23 (52.1 / 47.9) |
Renal replacement therapy before transplantation hemodialysis / peritoneal dialysis | 44 / 4 (91.7 / 8.3) |
Time on dialysis (months; mean ± SD) | 78.7 ± 32.8 |
Body mass index at transplantation (mean ± SD) | 24.2 ± 3.7 |
Transplantation data | |
Donor serum creatinine (μmol/l; mean ± SD) | 80.1 ± 36.5 |
Donor age (mean ± SD) | 45 ± 17 |
Donor gender (male; female) | 20 (43)/ 27 (57) |
Heterogeneous / homogeneous donor/recipient gender (female donor / male donor) | 20 (13 / 7) / 26 (15 / 11) |
Second or third kidney transplantation | 5 (10.4) |
Additional pancreas transplantation | 3 (6.3) |
Living donor transplantation | 8 (16.7) |
Eurotransplant Senior Program | 1 (2) |
Pre-formed antibodies > 0% | 3 (6) |
Mean number of HLA mismatches (A/B/DR) | 2.21 ± 1.3 |
Cold ischemic time (hours; mean ± SD) | 16.3 ± 9.5 |
Delayed graft function | 14 (29.2) |
CMV IgG positive recipient | 26 (55) |
Donor CMV IgG positive | 25 (53) |
Immunosuppressive therapy | |
Induction therapy: IL-2 AB / ATG / none / unknown | 38 / 3 / 6 / 1 (79.2 / 6.3 / 12.5 / 2.1) |
Ciclosporin A | 35 (72.9) |
Tacrolimus | 9 (18.8) |
Mycophenolate mofetil | 30 (62.5) |
Rapamycin | 4 (8.3) |
Steroids | 46 (95.8) |
Main reason for ESRF | |
Unknown | 17 (35.4) |
Glomerulonephritis | 15 (31.3) |
Tubulointerstitial disease | 4 (8.3) |
Hypertensive or diabetic nephropathy | 3 (6.3) |
Congenital disease | 8 (16.7) |
Other | 1 (2.1) |
Comorbidities before or at transplantation | |
Heart failure | 1 (2) |
Hypertension | 46 (95.8) |
Peripheral arterial disease | 5 (10.4) |
Coronary heart disease | 4 (8.3) |
Stroke | 1 (2.1) |
Hepatitis C | 2 (4.2) |
Diabetes type I / II | 4 (8.3) / 1 (2.1) |
Hypercholesterolemia | 20 (41.7) |
Smoking still present / given up / never / unknown | 4 / 11 / 25 / 8 (8.3 / 22.9 / 52.1 / 16.7) |
Pregnancies before actual transplantation | 19 (40) |
Blood transfusions before transplantation | 14 (30) |